The five-year-old Pacific trial on stage lll Non-small-cell cancer still reveals new findings.
In this MEDtalk the Chief Scientific Officer from Sarah Cannon research institute, David Speigel gives you the latest results from the five-year-old trial, that show a significant reduction in survival rates for patients.
